Sign in

CIK 0001636282 · Large accelerated filer

Spyre Therapeutics, Inc.

Sign in to watch
Ticker
SYRE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
464312787
Phone
6176515940
Business address
221 CRESCENT STREET, BUILDING 23, SUITE 105, WALTHAM, MA, 02453
Former names
Aeglea BioTherapeutics, Inc.
  1. SC 13G/A Stake Amended Statement of Ownership
  2. SC 13G/A Stake Amended Statement of Ownership
  3. SC 13G/A Stake Amended Statement of Ownership
  4. SC 13G/A Stake Amended Statement of Ownership
  5. SC 13G/A Stake Amended Statement of Ownership
  6. SC 13G/A Stake Amended Statement of Ownership
  7. 8-K Event Regulation FD disclosure · Other events
  8. 4 Insider Changes in Ownership
  9. SC 13G Stake Amended Statement of Ownership
  10. S-8 Other Securities Offered to Employees in Benefit Plans
  11. 8-K Event Results of operations
  12. 10-Q Report Quarterly Report
  13. 4 Insider Changes in Ownership
  14. 144 Insider Sale of Securities
  15. SC 13G Stake Amended Statement of Ownership
  16. SC 13G Stake Amended Statement of Ownership
  17. 8-K Event Material agreement · Regulation FD disclosure · Other events
  18. EFFECT Other Notice of Effectiveness
  19. 4 Insider Changes in Ownership
  20. 3 Insider Initial Statement of Ownership

Page 9 of 42 · 823 filings